500
Participants
Start Date
January 1, 2021
Primary Completion Date
March 30, 2028
Study Completion Date
June 30, 2028
Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
As part of routine treatment.
RECRUITING
Shandong Provincial Qianfoshan Hospital, Jinan
Qianfoshan Hospital
OTHER
The Second Hospital of Shandong University
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Shandong University
OTHER